These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8819002)

  • 41. In Vitro and In Vivo Correlation of Colon-Targeted Compression-Coated Tablets.
    Maity S; Kundu A; Karmakar S; Sa B
    J Pharm (Cairo); 2016; 2016():5742967. PubMed ID: 26989562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.
    Kleppe MS; Forney-Stevens KM; Haskell RJ; Bogner RH
    AAPS J; 2015 Jul; 17(4):902-17. PubMed ID: 25851513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations.
    Liu W; He X; Li Z; Gao X; Ma Y; Xun M; Liu C
    Pharm Res; 2013 Feb; 30(2):596-605. PubMed ID: 23135820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro-in vivo correlation: perspectives on model development.
    Lu Y; Kim S; Park K
    Int J Pharm; 2011 Oct; 418(1):142-8. PubMed ID: 21237256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From drug delivery systems to drug release, dissolution, IVIVC, BCS, BDDCS, bioequivalence and biowaivers.
    Karalis V; Magklara E; Shah VP; Macheras P
    Pharm Res; 2010 Sep; 27(9):2018-29. PubMed ID: 20635193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.
    Lukacova V; Woltosz WS; Bolger MB
    AAPS J; 2009 Jun; 11(2):323-34. PubMed ID: 19430911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of dissolution testing in quality by design.
    Dickinson PA; Lee WW; Stott PW; Townsend AI; Smart JP; Ghahramani P; Hammett T; Billett L; Behn S; Gibb RC; Abrahamsson B
    AAPS J; 2008 Jun; 10(2):380-90. PubMed ID: 18686045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system.
    Ginski MJ; Taneja R; Polli JE
    AAPS PharmSci; 1999; 1(2):E3. PubMed ID: 11741200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo-in vitro correlation (IVIVC) modeling incorporating a convolution step.
    O'Hara T; Hayes S; Davis J; Devane J; Smart T; Dunne A
    J Pharmacokinet Pharmacodyn; 2001 Jun; 28(3):277-98. PubMed ID: 11468941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities.
    Polli JE; Ginski MJ
    Pharm Res; 1998 Jan; 15(1):47-52. PubMed ID: 9487545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A population growth model of dissolution.
    Dokoumetzidis A; Macheras P
    Pharm Res; 1997 Sep; 14(9):1122-6. PubMed ID: 9327436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of novel prediction system of intestinal absorption in humans using human intestinal tissues.
    Miyake M; Toguchi H; Nishibayashi T; Higaki K; Sugita A; Koganei K; Kamada N; Kitazume MT; Hisamatsu T; Sato T; Okamoto S; Kanai T; Hibi T
    J Pharm Sci; 2013 Aug; 102(8):2564-71. PubMed ID: 23686795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel approach to the analysis of in vitro-in vivo relationships.
    Polli JE; Crison JR; Amidon GL
    J Pharm Sci; 1996 Jul; 85(7):753-60. PubMed ID: 8819002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro-in vivo correlation.
    Hou J; He X; Xu X; Shi X; Xu Y; Liu C
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1305-12. PubMed ID: 22296178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
    Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.